日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

EBF2 variant identified in a patient with atypical partial lipodystrophy causes adipose fibrosis and dysfunction

在一名患有非典型部分脂肪营养不良症的患者中发现的EBF2变异会导致脂肪纤维化和功能障碍。

Foss-Freitas, Maria C; Gilio, Donatella; Pais, Lynn; Buras, Eric D; Kaul Verma, Romil; O'Leary, Melanie; Rehm, Heidi L; Glaze, Carmen; Russell, Kathryn; Monteiro da Rocha, Andre; Neidert, Adam; Seale, Patrick; Udler, Miriam S; Oral, Elif A; Chun, Tae-Hwa

Refining Osteoarthritis Risk Prediction: Average Sagittal Abdominal Diameter Complements and Enhances Body Mass Index With Sex‐Specific Insights From National Health and Nutrition Examination Survey

完善骨关节炎风险预测:平均矢状腹径可补充并增强体重指数,并提供来自美国国家健康与营养调查的性别特异性信息

Meral, Rasimcan; Celik Guler, Merve; Kaba, Diarratou; Prativadi, Jeevitha; Frontera, Eric D; Foss-Freitas, Maria Cristina; Nachawi, Noura; Broome, David T; Lightbourne, Marissa; Brown, Rebecca J; Taylor, Simeon I; Oral, Elif A; Zhang, Yuwei; Wang, Xiaoshuai; Zhu, Hu; Chen, Haowei; Zhu, Zhaohua; Zhou, Liangbin; Ong, Michael Tim Yun; Shi, Dongquan; Zhang, Xin; Hunter, David J; Ding, Changhai; Tuan, Rocky S; Li, Zhong Alan

Clinical Guidance for Lipodystrophy Syndromes: From Diagnosis and Work-Up to Treatment

脂肪营养不良综合征临床指南:从诊断和检查到治疗

Gilio, Donatella; Foss-Freitas, Maria; Oral, Elif A

Lipodystrophy Syndromes: One Name but Many Diseases Highlighting the Importance of Adipose Tissue in Metabolism

脂肪营养不良综合征:一个名称,多种疾病,凸显脂肪组织在代谢中的重要性

Foss-Freitas, Maria; Gilio, Donatella; Oral, Elif A

GLP-1 RA and dual GIP/GLP-1 RA treatment in MODY: a descriptive case series

MODY患者的GLP-1受体激动剂和双重GIP/GLP-1受体激动剂治疗:病例系列描述

Mehdi, Alina Z; Deng, Lily; Chase, Colby L; Foss-Freitas, Maria Cristina; Gregg, Brigid; Naylor, Rochelle N; Oral, Elif A; Herman, William H; Krishnamurthy, Mansa; Broome, David T

Brazilian expert consensus on the diagnosis, classification, screening for complications and treatment of familial partial lipodystrophy

巴西专家就家族性部分脂肪营养不良的诊断、分类、并发症筛查和治疗达成共识

Valerio, Cynthia Melissa; Viola, Luiz F; Guidorizzi, Natália Rossin; Lima, Josivan Gomes; Godoy-Matos, Amélio F; Hohl, Alexandre; Trujilho, Fabio R; Dantas, Joana R; de Melo Campos, Julliane Tamara Araújo; Zajdenverg, Lenita; Muniz, Raquel Beatriz Gonçalves; Moreira, Rodrigo Oliveira; Fernandes, Virgínia Oliveira; Foss-Freitas, Maria Cristina; Montenegro, Renan Jr

Calf skinfold measurements as a diagnostic tool for lipodystrophy syndromes: a cross-sectional study

小腿皮褶厚度测量作为脂肪营养不良综合征的诊断工具:一项横断面研究

da Cruz Paiva Lima, Grayce Ellen; de Moura Lopes, Fabia Karine; Araújo, Jessica Silveira; Boris, Natália Prado; Fernandes, Virginia Oliveira; Veras, Victor Rezende; Sales, Mayara Teixeira Alexandrino; Ramos, Lorena Taúsz Tavares; Flor, Amanda Caboclo; Montenegro, Ana Paula Dias Rangel; Castelo, Maria Helane Gurgel; Ponte, Clarisse Mourao Melo; Verde, Júlia Lemos Lima; Foss-Freitas, Maria C; Montenegro Junior, Renan Magalhães

Genetics Evaluation Outcomes From an Academic Multidisciplinary Atypical Diabetes Program

来自学术多学科非典型糖尿病项目的遗传学评估结果

Chase, Colby L; Accardo, Marie-Louise; Greve, Veronica; Ames, Elizabeth G; Quinonez, Shane C; Scott, Anthony; Hipp, Lauren; Damon, Jenna; Uhlmann, Wendy R; Broome, David T; Foss-Freitas, Maria C; Akinci, Baris; Neidert, Adam H; Narla, Goutham; Oral, Elif A; Lee, Kristen N

Potential Impact of Parental Origin of Inheritance on the Clinical Presentation of Familial Partial Lipodystrophy Type 2 Syndrome

父母遗传来源对家族性部分脂肪营养不良2型综合征临床表现的潜在影响

Gilio, Donatella; Besci, Ozge; Guidorizzi, Natália Rossin; Guler, Merve Celik; Simsir, Ilgin Yildirim; Pelosini, Caterina; Ceccarini, Giovanni; Demir, Korcan; Akinci, Baris; Santini, Ferruccio; Foss-Freitas, Maria Cristina; Oral, Elif A

Response to Comment on Foss-Freitas et al. Efficacy and Safety of Glucagon-Like Peptide 1 Agonists in a Retrospective Study of Patients With Familial Partial Lipodystrophy. Diabetes Care 2024;47:653-659

对 Foss-Freitas 等人发表的题为“回顾性研究中胰高血糖素样肽-1激动剂治疗家族性部分脂肪营养不良患者的疗效和安全性”的文章的回应。Diabetes Care 2024;47:653-659

Foss-Freitas, Maria C; Broome, David T; Oral, Elif A